The Latin America, Middle East and Africa Microcarriers Market should witness market growth of 16.8% CAGR during the forecast period (2022-2028).
The microcarrier-suspension systems' homogeneity enables the monitoring and regulation of a number of environmental variables, including pH, oxygen tension (pO2), nutrient and metabolite content, and others. More repeatable cell cultures result from improved system control.
The stirred-tank bioreactor, which is used for suspension cell cultures, is a standard piece of equipment that can implement large-scale cultures employing microcarriers quite readily (eg, mammalian cells). Microcarriers also enable scale-up through bead-to-bead cell transfer without the requirement for enzymatic dissociation, which affects the quality of cell output.
The microcarrier technology results in a decrease in laboratory and storage space, a reduction in the work required for routine production, and bigger cell densities as compared to typical static culture systems. Additionally, fewer handling procedures are needed to achieve a certain number of cells, lowering the chance of contamination.
The healthcare sector in the Middle East is experiencing tremendous growth due to various factors, such as government measures to promote medical tourism, changing health insurance laws, and a rising predisposition among the local population to use digital health services. Global healthcare companies are attempting to identify the best business model as they perceive this as a significant growth opportunity. Relationships with IT service providers change as growth strategies for healthcare businesses do, especially now that technology is a crucial component of healthcare funding and delivery.
The Brazil market dominated the LAMEA Microcarriers Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $46.7 million by 2028. The Argentina market is experiencing a CAGR of 17.4% during (2022-2028). Additionally, The UAE market would display a CAGR of 16.4% during (2022-2028).
Based on Consumables, the market is segmented into Microcarrier Beads and Media & Reagents. Based on Microcarrier Beads Type, the market is segmented into, Collagen Coated Beads, Cationic Beads, Protein Coated Beads, Untreated Beads and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations and Academic & Research Institutes. Based on Application, the market is segmented into Biopharmaceutical Production and Regenerative Medicine. Based on Biopharmaceutical Production Type, the market is segmented into Vaccine Production and Therapeutic Production. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Sartorius Stedim Biotech S.A. (Sartorius AG), Corning Incorporated, Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf SE, HiMedia Laboratories Pvt. Ltd., and denovoMATRIX GmbH.
The microcarrier-suspension systems' homogeneity enables the monitoring and regulation of a number of environmental variables, including pH, oxygen tension (pO2), nutrient and metabolite content, and others. More repeatable cell cultures result from improved system control.
The stirred-tank bioreactor, which is used for suspension cell cultures, is a standard piece of equipment that can implement large-scale cultures employing microcarriers quite readily (eg, mammalian cells). Microcarriers also enable scale-up through bead-to-bead cell transfer without the requirement for enzymatic dissociation, which affects the quality of cell output.
The microcarrier technology results in a decrease in laboratory and storage space, a reduction in the work required for routine production, and bigger cell densities as compared to typical static culture systems. Additionally, fewer handling procedures are needed to achieve a certain number of cells, lowering the chance of contamination.
The healthcare sector in the Middle East is experiencing tremendous growth due to various factors, such as government measures to promote medical tourism, changing health insurance laws, and a rising predisposition among the local population to use digital health services. Global healthcare companies are attempting to identify the best business model as they perceive this as a significant growth opportunity. Relationships with IT service providers change as growth strategies for healthcare businesses do, especially now that technology is a crucial component of healthcare funding and delivery.
The Brazil market dominated the LAMEA Microcarriers Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $46.7 million by 2028. The Argentina market is experiencing a CAGR of 17.4% during (2022-2028). Additionally, The UAE market would display a CAGR of 16.4% during (2022-2028).
Based on Consumables, the market is segmented into Microcarrier Beads and Media & Reagents. Based on Microcarrier Beads Type, the market is segmented into, Collagen Coated Beads, Cationic Beads, Protein Coated Beads, Untreated Beads and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations and Academic & Research Institutes. Based on Application, the market is segmented into Biopharmaceutical Production and Regenerative Medicine. Based on Biopharmaceutical Production Type, the market is segmented into Vaccine Production and Therapeutic Production. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Sartorius Stedim Biotech S.A. (Sartorius AG), Corning Incorporated, Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf SE, HiMedia Laboratories Pvt. Ltd., and denovoMATRIX GmbH.
Scope of the Study
By Consumables
- Microcarrier Beads
- Collagen Coated Beads
- Cationic Beads
- Protein Coated Beads
- Untreated Beads
- Others
- Media & Reagents
By End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations & Contract Manufacturing Organizations
- Academic & Research Institutes
By Application
- Biopharmaceutical Production
- Vaccine Production
- Therapeutic Production
- Regenerative Medicine
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Merck Group
- Sartorius Stedim Biotech S.A. (Sartorius AG)
- Corning Incorporated
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Eppendorf SE
- HiMedia Laboratories Pvt. Ltd.
- denovoMATRIX GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Microcarriers Market by Consumables
Chapter 4. LAMEA Microcarriers Market by End-user
Chapter 5. LAMEA Microcarriers Market by Application
Chapter 6. LAMEA Microcarriers Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck Group
- Sartorius Stedim Biotech S.A. (Sartorius AG)
- Corning Incorporated
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Eppendorf SE
- HiMedia Laboratories Pvt. Ltd.
- denovoMATRIX GmbH
Methodology
LOADING...
